Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis

被引：0

作者：

Gadi Lending

Yousef Abed El Ghani

Edward Kaykov

Boris Svirsky

Hector Isaac Cohen

Edward Altman

机构：

[1] Western Galilee Medical Center,Department of Internal Medicine – Geriatrics

[2] The Pathology and Cytology Units,undefined

[3] Western Galilee Medical Center,undefined

[4] Department of Thoracic Surgery,undefined

[5] western Galilee medical center,undefined

来源：

Indian Journal of Surgical Oncology | 2021年 / 12卷

关键词：

Hemorrhagic malignant pleural effusion; Talc pleurodesis; Thoracoscopy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Hemorrhagic malignant pleural effusion (HMPE) is diagnosed in 47–50% of all malignant pleural effusions (MPE). The aim of this study is to evaluate clinical, radiological, and morphological manifestations of HMPE and results of talc pleurodesis treatment. This is a retrospective review of the medical charts of 135 MPE patients which consists of HMPE group (42 patients) and simple MPE group (63 patients) (median age 67.9 years; 43 males, 62 females). In HMPE vs. simple MPE patients, pronounced dyspnea (100% vs. 88.9%, P = 0.024), chest pain (59.5% vs. 60.3%, P = 1), general deterioration (78.6% vs. 74.6%, P = 0.411) combined with large pleural effusion (81% vs. 50.8%, P = 0.001), and thickening of parietal pleura (73.8% vs. 68.3%, P = 0.349), all were more specific for HMPE.

引用

页码：54 / 60

页数：6